Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-17

Clinical Trial Update: Local Infusion of Ropivacaine for Post-Op Pain Control After Osseocutaneous Free Flaps [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating local infusion of ropivacaine for postoperative pain control after osseocutaneous free flap procedures in head and neck cancer patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Head and Neck Cancer, Free Tissue Transfer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-17